Caers J, Paiva B, Zamagni E, Leleu X, Bladé J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosiñol L (2018) Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European expert panel. J Hematol Oncol 11:10. https://doi.org/10.1186/s13045-017-0549-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kyle R, Rajkumar S, Myeloma (2009) Treatment of multiple myeloma: a comprehensive review. Clin Lymphoma 9:278–288. https://doi.org/10.3816/CLM.2009.n.056

Article  CAS  Google Scholar 

Fend F, Dogan A, Cook JR (2023) Plasma cell neoplasms and related entities-evolution in diagnosis and classification. Virchows Archiv Int J Pathol 482:163–177. https://doi.org/10.1007/s00428-022-03431-3

Article  CAS  Google Scholar 

Callander NS, Baljevic M, Adekola K, Anderson LD, Campagnaro E, Castillo JJ, Costello C, Devarakonda S, Elsedawy N, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Liedtke M, Martin T, Omel J, Sborov D, Shain K, Stockerl-Goldstein K, Weber D, Berardi RA, Kumar R, Kumar SK (2022) NCCN guidelines® Insights: multiple myeloma, version 3.2022. J Natl Compr Cancer Netw JNCCN 20:8–19. https://doi.org/10.6004/jnccn.2022.0002

Article  PubMed  Google Scholar 

van de Donk N, Pawlyn C, Yong KL (2021) Multiple myeloma. Lancet (London, England) 397:410–427. https://doi.org/10.1016/s0140-6736(21)00135-5

Article  CAS  PubMed  Google Scholar 

Xie L, Wang H, Jiang J (2020) Does radiotherapy with surgery improve survival and decrease progression to multiple myeloma in patients with solitary plasmacytoma of bone of the spine? World Neurosurg 134:e790–e798. https://doi.org/10.1016/j.wneu.2019.11.002

Article  PubMed  Google Scholar 

Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A (2012) A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Sci World J 2012:895765. https://doi.org/10.1100/2012/895765

Article  Google Scholar 

Cowan A, Green D, Kwok M, Lee S, Coffey D, Holmberg L, Tuazon S, Gopal A, Libby E (2022) Diagnosis and management of multiple myeloma: a review. JAMA 327:464–477. https://doi.org/10.1001/jama.2022.0003

Article  CAS  PubMed  Google Scholar 

Missenard G, Bouthors C, Fadel E, Court C (2020) Surgical strategies for primary malignant tumors of the thoracic and lumbar spine. Orthop Traumat Surg Res OTSR 106:S53–S62. https://doi.org/10.1016/j.otsr.2019.05.028

Article  Google Scholar 

Zadnik P, Goodwin C, Karami K, Mehta A, Amin A, Groves M, Wolinsky J, Witham T, Bydon A, Gokaslan Z, Sciubba D (2015) Outcomes following surgical intervention for impending and gross instability caused by multiple myeloma in the spinal column. J Neurosurg Spine 22:301–309. https://doi.org/10.3171/2014.9.Spine14554

Article  PubMed  Google Scholar 

Zijlstra H, Pierik RJ, Crawford AM, Tobert DG, Wolterbeek N, Oosterhoff JHF, Delawi D, Terpstra WE, Kempen DHR, Verlaan JJ, Schwab JH (2023) Analysis of complications and revisions after spine surgery in 270 multiple myeloma patients with spinal involvement. Eur Spine J. https://doi.org/10.1007/s00586-023-07903-1

Article  PubMed  Google Scholar 

Guzik G (2017) Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma. BMC Surg 17:92. https://doi.org/10.1186/s12893-017-0288-9

Article  PubMed  PubMed Central  Google Scholar 

Cai W, Yan W, Huang Q, Huang W, Yin H, Xiao J (2015) Surgery for plasma cell neoplasia patients with spinal instability or neurological impairment caused by spinal lesions as the first clinical manifestation. Eur Spine J 24:1761–1767. https://doi.org/10.1007/s00586-014-3679-y

Article  PubMed  Google Scholar 

Ouyang H, Han S, Jiang L, Zhuang H, Yang S, Liu Y, Zhang L, Liu X, Wei F, Chen K, Zhou S, Liu Z (2020) Reossification and prognosis following radiotherapy with/without surgery for spinal solitary plasmacytoma of the bone: a retrospective study of 39 patients. Spine J 20:283–291. https://doi.org/10.1016/j.spinee.2019.09.018

Article  PubMed  Google Scholar 

Rafique R, Islam S, Kazi J (2021) Machine learning in the prediction of cancer therapy. Comput Struct Biotechnol J 19:4003–4017. https://doi.org/10.1016/j.csbj.2021.07.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunze K, Krivicich L, Clapp I, Bodendorfer B, Nwachukwu B, Chahla J, Nho S (2022) Machine learning algorithms predict achievement of clinically significant outcomes after orthopaedic surgery: a systematic review. Arthrosc J Arthrosc Rel Surg 38:2090–2105. https://doi.org/10.1016/j.arthro.2021.12.030

Article  Google Scholar 

Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ (Clin Res ed) 350:g7594. https://doi.org/10.1136/bmj.g7594

Article  Google Scholar 

Bilsky MH, Laufer I, Fourney DR, Groff M, Schmidt MH, Varga PP, Vrionis FD, Yamada Y, Gerszten PC, Kuklo TR (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13:324–328. https://doi.org/10.3171/2010.3.Spine09459

Article  PubMed  Google Scholar 

Yang L, Wang F, Zhang H, Yang X, Zhang H, Li J, Qiao R, Zhang G, Hu Y (2019) Patient characteristics following surgery for spinal metastases: a multicenter retrospective study. Orthop Surg 11:1039–1047. https://doi.org/10.1111/os.12551

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412–3420. https://doi.org/10.1200/jco.2005.04.242

Article  PubMed  Google Scholar 

Amelot A, Cristini J, Salaud C, Moles A, Hamel O, Moreau P, Bord E, Buffenoir K (2017) Overall survival in spine myeloma metastases: difficulties in predicting with prognostic scores. Spine 42:400–406. https://doi.org/10.1097/brs.0000000000001766

Article  PubMed  Google Scholar 

Amelot A, Moles A, Cristini J, Salaud C, Touzeau C, Hamel O, Bord E, Buffenoir K (2016) Predictors of survival in patients with surgical spine multiple myeloma metastases. Surg Oncol 25:178–183. https://doi.org/10.1016/j.suronc.2016.05.012

Article  PubMed  Google Scholar 

Shen J, Du X, Zhao L, Luo H, Xu Z (2018) Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue. Oncol Lett 15:10017–10025. https://doi.org/10.3892/ol.2018.8559

Article  PubMed  PubMed Central  Google Scholar 

Cox DR (1972) Regression models and life tables (With discussion). J R Stat Soc Ser B Method. https://doi.org/10.1111/j.2517-6161.1972.tb00899.x

Article  Google Scholar 

Hari PN, Zhang MJ, Roy V, Pérez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Vesole D (2009) Is the International staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia 23:1528–1534. https://doi.org/10.1038/leu.2009.61

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Chen B, Shao R, Liu W, Xiong L, Li L, Lu Y (2022) A new prediction model integrated serum lipid profile for patients with multiple myeloma. J Cancer 13:1796–1807. https://doi.org/10.7150/jca.69321

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dolloff N, Talamo G (2013) Targeted therapy of multiple myeloma. Adv Exp Med Biol 779:197–221. https://doi.org/10.1007/978-1-4614-6176-0_9

Article  CAS  PubMed  Google Scholar 

Lei M, Kim E, Branagan A, Lou U, Zemel M, Raje N (2019) Current management and emerging treatment strategies for multiple myeloma. Jpn J Clin Hematol 60:1243–1256. https://doi.org/10.11406/rinketsu.60.1243

Article  Google Scholar 

Cohen Y, Joffe E, Benyamini N, Dimopoulos M, Terpos E, Trestman S, Held-Kuznetsov V, Avivi I, Kastritis E (2016) Primary failure of bortezomib in newly diagnosed multiple myeloma—understanding the magnitude, predictors, and significance. Leukemia Lymphoma 57:1382–1388. https://doi.org/10.3109/10428194.2015.1121258

Article  CAS  PubMed  Google Scholar 

Dima D, Jiang D, Singh DJ, Hasipek M, Shah HS, Ullah F, Khouri J, Maciejewski JP, Jha BK (2022) Multiple myeloma therapy: emerging trends and challenges. Cancers. https://doi.org/10.3390/cancers14174082

Article  PubMed  PubMed Central  Google Scholar 

Tsang R, Campbell B, Goda J, Kelsey C, Kirova Y, Parikh R, Ng A, Ricardi U, Suh C, Mauch P, Specht L, Yahalom J (2018) Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group. Int J Radiation Oncol Biol Phys 101:794–808. https://doi.org/10.1016/j.ijrobp.2018.05.009

Article  Google Scholar 

Tancioni F, Lorenzetti M, Navarria P, Nozza A, Castagna L, Gaetani P, Aimar E, Levi D, Di Ieva A, Pisano P, Santoro A, Scorsetti M, Rodriguez y Baena R (2010) Vertebroplasty for pain relief and spinal stabilization in multiple myeloma. Neurol Sci Off J Ital Neurol Sci 31:151–157. https://doi.org/10.1007/s10072-009-0197-5

Article  Google Scholar